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Abstract
In this work we explore the temporal dynamics of spatial heterogeneity
during the process of tumorigenesis from healthy tissue. We utilize a spatial
stochastic process model of mutation accumulation and clonal expansion in
a structured tissue to describe this process. Under a two-step tumorigenesis
model, we first derive estimates of a non-spatial measure of diversity: Simp-
son’s Index, which is the probability that two individuals sampled at random
from the population are identical, in the premalignant population. We next
analyze two new measures of spatial population heterogeneity. In particular
we study the typical length scale of genetic heterogeneity during the carcino-
genesis process and estimate the extent of a surrounding premalignant clone
given a clinical observation of a premalignant point biopsy. This evolutionary
framework contributes to a growing literature focused on developing a better
understanding of the spatial population dynamics of cancer initiation and pro-
gression. Although initially motivated by understanding questions in cancer,
these results can be applied more generally to help understand the dynam-
ics of heterogeneity and diversity in a variety of spatially structured, evolving
populations.
1 Introduction
Carcinogenesis, the transformation from healthy tissue to invasive cancer, is a
lengthy and complex process driven by a variety of factors including hereditary
predisposition [1], exposure to environmental factors [2] and a changing microenvi-
ronment in the affected organ [3]. Irrespective of the driving factors, most cancers
are characterized by the progressive accumulation of genetic alterations in a small
group of founder cells. These alterations are either deleterious or neutral (passenger
mutation), and some can confer a fitness advantage to the affected cell (driver mu-
tation) by increasing the reproductive rate or inhibiting cell-regulatory mechanisms
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[4]. These selective advantages in turn lead to clonal expansion of a mutant cell
population, which provides a fertile backdrop for further genetic alterations. Im-
portantly, the underlying tissue architecture strongly influences the spatial growth
patterns of the premalignant lesions, leading to complex patterns of spatial hetero-
geneity caused by competing and overlapping clones of various sizes and genetic
ancestries [5].
The extent of spatial heterogeneity arising from this evolutionary process has
been shown to correlate with clinical outcome. For example, genetic clonal diver-
sity in premalignant tissue found in cases of Barrett’s esophagus has been shown
to predict progression to esophageal carcinoma [6]. However, the translation of
heterogeneity into a patient-specific clinical progression markers remains challeng-
ing because multiple point biopsies per patient are needed to reliably ascertain the
degree of heterogeneity. Thus, there is a critical need for quantitative tools that
(i) inform optimal sampling strategies, (ii) infer the degree of heterogeneity in pre-
malignant tissue based on sparse sample data, and (iii) predict the evolution of
premalignant lesions and time scale of progression.
In this work we develop and analyze a cell-based stochastic model that describes
the evolutionary process of cancer initiation in a spatially structured tissue. This
model is a spatial version of a Moran population model, and has previously been
analyzed in [7, 8, 9]. Using a mesoscopic approximation of this model, we analyze two
spatial measures of heterogeneity that are relevant for the clinical setting. First, we
study the probability that two samples, taken a fixed distance apart from each other,
are genetically identical. This corresponds to a spatial analog of Simpsons’ Index, a
traditionally non-spatial measure of diversity which is defined as the probability that
two individuals sampled at random from a population are identical. This measure,
taken as a function of the distance between samples, provides an estimate of the
length scale of heterogeneity in the premalignant tissue. As a second measure of
heterogeneity, we study the expected size of a premalignant lesion. This measure
may be useful in scenarios where an isolated point biopsy indicates premalignant
tissue without further information about the extent of the lesion. For both measures,
we determine how they evolve during the transformation from healthy tissue to onset
of malignancy, and we characterize their dependence on cancer-specific parameters
such as mutation rates and fitness advantages. Due to the general formulation of
the model, these results provide a useful tool for studying how heterogeneity and
the extent of premalignant lesions vary between different cancer types. Although
initially motivated by understanding questions in cancer, these results can be applied
more generally to help understand the dynamics of heterogeneity and diversity in a
variety of spatially structured, evolving populations.
The influence of spatial structure on the diversity of evolving populations has
previously been studied in the ecological literature. Within that context, R.H.
Whittaker introduced the measures of α-,β- and γ-diversity to denote the average
species richness at the single habitat level (α), the diversity between habitats (β),
and total species richness (γ) [10]. These measures are useful to quantify large
scale organismal diversity in an ecological setting with spatial variation between
well-defined habitats. However in the present work we are interested in developing
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new measures of diversity to explore more specifically the intrinsic length scales of
genetic heterogeneity driven by clonal expansion dynamics in a spatially structured
tissue population.
There have been other mathematical modeling efforts on the topic of heterogene-
ity during cancer initiation and expansion. In particular, previous work by Iwasa
and Michor explored the Simpson’s Index in a Moran process of tumorigenesis [11].
This study focused on understanding the impact of neutral and advantageous mu-
tations in a non-spatial, homogeneously mixed population setting. The work by
Durrett and et. al. [12] developed formulas for Simpson’s Index and other hetero-
geneity measures in a multitype branching process model of cancer evolution. More
recently, Dhawan and colleagues [13] developed a computational platform for the
comparison of alternative spatial heterogeneity measures as potential biomarkers for
tumor progression. Finally, within the broader context of spatial tumor growth, our
work adds to a vast body of literature, e.g. [14, 15, 16, 17, 18, 7].
The outline of this paper is as follows: In Section 2 we introduce a cell-based
stochastic evolutionary model of spatial carcinogenesis, as well as a mesoscopic ap-
proximation to this model that was analyzed in [8]. In Section 3 we first analyze
the non-spatial Simpson’s Index for this spatially-structured population. Then, in
Section 4 we formulate and analyze two clinically relevant spatial measures of het-
erogeneity and study their dependence on cancer-specific parameters. Finally, we
summarize and discuss our findings in Section 5.
2 Model
We introduce a spatial evolutionary model that describes the dynamic transition
from physiological homeostasis to onset of invasive cancer. In between, the tissue
undergoes a sequence of genetic changes that manifest themselves at the phenotypic
level in the form of increased proliferation rates, and hence a fitness advantage of
mutant cells over normal cells. It is important to note that in many cancers, there
is a succinct lack of a clearly defined genetic sequence [19]. On the other hand,
the morphological changes from normal tissue to dysplasia, carcinoma in situ and
invasive cancer is common in carcinomas, which account for over 80% of all cancers.
Therefore, one might prefer to interpret mutations as phenotypic transitions rather
than genetic aberrations. With this interpretation in mind, we are going to introduce
a linear 3-stage model, where type 0 cells represent normal tissue, type 1 cells are
pre-malignant (dysplasia/CIS) and type 2 cells are malignant cancer cells. Note
that the model can be extended to a setting with more than two mutations, either
to represent a more refined phenotypic progression, or to account for select cancer-
specific genetic events.
To render this model spatial, we introduce a cell-based stochastic model on the
integer lattice Zd ∩ [−L/2, L/2]d, where L > 0, and equip this domain with periodic
boundary conditions. On this lattice we have three different types of cells, labeled
as type 0, type 1 and type 2. For i ∈ {0, 1, 2} a type i cell reproduces at rate (1+s)i,
and when the cell reproduces it replaces one of its 2d neighboring cells at random.
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In addition, we assume that for i ∈ {0, 1}, a type i cell mutates to type i + 1 at
rate ui+1. Initially our entire lattice is occupied by type 0 cells which represent
normal cells without any oncogenic mutations. Tumor initiation is defined as the
birth of the first type-2 cell that does not go extinct. In the biological application
we are interested in (somatic cells in the body) L is generally at least 106 while s,
u1 and u2 are quite small. Therefore we will, unless stated otherwise, restrict our
analysis to the regime L  1, u1  1, u2  1, and s  1. Before we can discuss
the specific conditions imposed on the model parameters, we need to review the
dynamic properties of the model.
In [8] we established that the arrival of type-1 mutants that are successful (i.e.
whose progeny does not go extinct) can be described as a Poisson process with rate
u1s/(1 + s). Here, u1 is the mutation rate to type-1 and s/(1 + s) is the survival
probability of each type-1 mutant. We also characterized the radial expansion rate
of type-1 families as a function of the selective advantage s in each dimension. In
particular, it was established in [20, 21] that each successful type-1 family has an
asymptotic shape D which is a unit ball in an unknown norm, and grows linearly in
time. Let e1 the unit vector in the first axis, and let cd(s) be the linear expansion rate
of the radius of this ball: D ∩ {ze1 : z ∈ R} = [−cd(s), cd(s)]. Then, we established
that as s→ 0,
cd(s) ∼

s d = 1√
4pis/ log(1/s) d = 2√
4βds d ≥ 3,
where βd is the probability that two d dimensional simple random walks started at
0 and e1 = (1, 0, . . . , 0) never collide.
Based on this result, we then introduced a mesoscopic approximation to the
model. Here, the growth of successful mutant families is deterministic while the
arrival of these families follows a non-homogeneous Poisson process. To ensure that
this mesocopic model accurately recapitulates the dynamics of the cell-based model,
we will make the following assumptions on the relationships between parameters in
the model:
(A0) u1  1/`(s)(d+2)/2 (1)
(A1)
(
cd
u2s
)d/(d+1)
 N
(A2) (Nu1s)
d+1(cddu2s)
−1 → c ∈ [0,∞) (2)
(A3) u2  1/`(s)
These assumptions generally hold for the parameter ranges appropriate for our bio-
logical application of carcinogenesis, see [8] for a details. In addition, we will focus
on dimensions d = 1 and d = 2 since most epithelial tissues can be viewed as one
or two dimensional structures, e.g., the cells lining a mammary duct (d = 1), the
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crypts in the colon (d = 2), or the stratified squamous epithelia of bladder, the
cervix and the skin (d = 2).
In the simplified mesoscopic model we consider the cells to live on a spatial
continuum D = [−L,L]d. The state-space of the system is given by a set-valued
function χt, which characterizes the regions of D occupied by type-1 cells at time t.
Mutations to type-1 cells occur as a Poisson process at rate u1s in the set χ
c
t = D\χt,
i.e. in regions where type-0 cells reside. Each newly created type-1 mutation initiates
an expanding ball whose radius grows linearly at rate cd. Denoting the Euclidean
ball by Bx,r = {y : ||y − x|| ≤ r}, then after k mutations at the space-time points
{(x1, t1), . . . , (xk, tk)}, we have
χt =
k⋃
i=1
Bxi,cd(t−ti).
Thus, the state of the system at any time t is the union of balls occupied by ex-
panding mutant type-1 families. In [8] we proved that under assumption (A2) we
can neglect the possibility that a second mutation arises from a type-1 family that
dies out eventually. Therefore, we model successful type-2 mutations as Poisson
arrivals into the space occupied by type-1 cells, χt, with rate u2s. Recall that in our
two-step cancer initiation model, the type-2 mutant represents a malignant cancer
cell.
We define the cancer initiation time σ2 as the time when the first successful
type 2 cell is born. Then, σ2 is a random variable with complimentary cumulative
distribution function given by
P (σ2 > t) = E exp
(
−u2s
∫ t
0
|χt|dt
)
,
where |χt| is the area of type-1 cells at time t.
3 Simpson’s Index
Simpson’s Index, a traditional non-spatial measure of heterogeneity, is defined as the
probability that two individuals, sampled at random from a population, are geneti-
cally identical. More precisely, if there are N types of individuals in a population,
the Simpson’s Index is defined as
R =
N∑
i=1
(
Yi
Y
)2
, (3)
where Yi is the number of individuals of the i-th type, and Y is the size of the entire
population. Although this measure is usually used to characterize well-mixed popu-
lations, we investigate here how it evolves over time within the spatially structured
population described by the mesoscopic spatial model from Section 2. In the cancer
setting, one question of interest is to determine the degree of heterogeneity of the
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premalignant cell population. In our mesoscopic model, suppose there are Nt type-1
clones present at time t > 0. We then extend definition (3) as the time-dependent
quantity
R(t) =
Nt∑
i=1
(
Y1,i(t)
Y1(t)
)2
, (4)
where Nt is a Poisson random variable with parameter Nu1st, Y1,i denotes the
volume of the type-1 subclone originating from the ith type 1 mutation, and Y1(t) is
the total volume of all the type-1 families present at time t, i.e. Y1(t) =
∑Nt
k=1 Y1,i(t).
From conditions (A0)-(A3) and Theorem 4 of [8] we know that overlaps between
distinct type-1 clones occur with negligible probability by time σ2; we therefore
ignore this possibility in the computation of Simpson’s Index.
Building on the theory of size-biased permutations, it is possible to characterize
the distribution of R(t) as follows.
Proposition 3.1. The conditional expectation of Simpson’s Index for the spatial
mesoscopic model is
E[R(t)|Nt = n] = nE
[(
S1
Sn
)2]
, (5)
where Sn := B1 + . . .+Bn with Bi are i.i.d. Beta(
1
d , 1) random variables.
The proof of this result is found in Appendix A.2.
Proposition 3.2. The conditional variance of the Simpson’s Index is bounded as
follows
[E (R(t) | Nt = n)]2 ≤ n
∫ ∞
0
∫ ∞
0
( r
x
)3
ν1(r) νn−1(x− r) dx dr, (6)
where νk is the probability density function of Sk as defined above.
The derivation of this bound is found in Appendix A.3. Finally, the following
result establishes the behavior of Simpson’s Index for large n.
Proposition 3.3. Conditioned on Nt = n, R(t) converges to zero in probability as
n→∞.
This result tells us that as the number of clones increases, the probability of
selecting two cells from the same clone goes to zero.
Next, we use Monte Carlo simulations to evaluate (5) and study the temporal
evolution of Simpson’s Index (see Appendix A.5 for details on evaluating (5)). In
Figure 1, we observe that the index first increases until it reaches a maximum, and
then starts decaying in a monotone fashion. Essentially, this result stems from the
fact that in the early phase of the model the first few clones are developing and
expanding, so samples are becoming more likely to be from the same clone. As
6
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Figure 1: Time-dependence of non-spatial Simpson’s Index R(t). The tem-
poral evolution of the expected value of the non-spatial Simpson’s Index is shown
(A) for varying values of the mutation rate u1, and (B) for varying values of the
fitness advantage s of preneoplastic cells over normal cells. In both simulations:
M1 = M2 = 500, N = 10
4, and u1 = 7.5× 10−7, s = 0.1 unless specified.
more mutations are produced the population diversifies. Then, Simpson’s Index
decreases as it becomes less likely for two cells to be from the same family. Note
that this is consistent with the result in Proposition 3.3. Figure 1A illustrates that
as the mutation rate u1 increases, this process of establishing mutant families and
diversification occurs faster. In particular, the maximum Simpson’s Index decreases
with increasing mutation rate because the time periods in which only a single clone
exists become shorter. Finally, Figure 1B shows that as the selective advantage s
is increased, the growth of mutant families and diversification occurs faster due to
the faster spread of mutant cells. A possible implication of this result is that more
aggressive tumors will have a higher level of heterogeneity.
4 Spatial measures of heterogeneity
In the clinical setting, the spatial heterogeneity of premalignant tissues poses con-
siderable challenges. It is standard practice to take one biopsy sample from an
arbitrary location in a suspected premalignant tissue, and to use molecular infor-
mation from this sample to determine whether it is (pre)cancerous as well as its
specific cancer sub-type, if applicable. This information is used to help guide the di-
agnosis, prediction of prognosis and treatment strategies. Due to the heterogeneity
of premalignant tissue, such a single-biopsy approach may lead to incorrect subtype
labeling or diagnoses, and subsequently to suboptimal therapeutic measures. For
example, the spatial extent of this clone is unknown and thus surgical excision or
prognosis prediction may be difficult. In view of these issue, the analysis of several
biopsies across the tumor mass upon excision seems necessary. However, this raises
another question of the length-scale of heterogeneity: how fine or coarse should the
spatial sampling be, i.e. how many sections are required for a representative genetic
fingerprint of the heterogeneous tissue?
In order to gain insight into these issues, we focus here on two specific clinical
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questions and introduce corresponding measures of spatial heterogeneity.
• Question 1: Given a region of premalignant tissue, what is the expected length-
scale of heterogeneity? (i.e. how far apart should biopsy samples be taken?)
• Question 2: Provided that only a single point biopsy is available, what is the
expected size of the clone present at the biopsy?
Before we introduce analytical expressions for these two measures of spatial hetero-
geneity I1 and I2, we introduce notation that will be useful below. Suppose two
type-1 mutations occur at space-time points (x0, t1) and (y0, t2), respectively. Then
the two clones will collide at time
t∗ =
t1 + t2
2
+
||x0 − y0||
2cd
.
Define the vector v = (y − x)/||y − x||. Then the first interaction between the two
clones occurs at location
v∗ = x0 + cdv(t∗ − t1) = y0 − cdv(t∗ − t2).
Next define the half-spaces
H+ = {x ∈ Rd : 〈x, v∗〉 > 0} and H− = {x ∈ Rd : 〈x, v∗〉 < 0},
where 〈·, ·〉 is the inner product in Rd. If x0 ∈ H+ and y0 ∈ H− then the region of
space influenced by the mutation that occurred at (x0, t1) is
Bx0,cd(t−t1) ∩H+,
and similarly the region influenced by the mutation that occurred at (y0, t2) is given
by
By0,cd(t−t2) ∩H−.
Note that we still have
χt = Bx0,cd(t−t1) ∪By0,cd(t−t2)
but we have decomposed χt into regions influenced by the two distinct mutations.
4.1 Spatial measure I1: length scale of heterogeneity
A mutation at point (ti, xi) generates a ball Bxi,cd(s)(t−ti) growing linearly in t. Thus
barring interference, at time t > ti, the type 1 family is of size
Y1,i(t) = γdc
d
d(s) (t− ti)d , (7)
where γd is the volume of the d-dimensional unit sphere. To determine the length-
scale of spatial heterogeneity, consider a fixed distance r > 0 and pick two cells
separated by r uniformly at random. We define I1(r, t) to be the probability that
these two cells are genetically identical (from the same mutant clonal expansion)
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at time t. The functional dependence of I1(r, t) on r provides an estimate of the
length scale of heterogeneity and thus may provide guidance on sampling proce-
dures. For example, a suggested sampling distance r50 ≡ {argminr>0I1(r, t) < 0.5}
between biopsies would ensure that sampled clones would be genetically different
from neighboring samples 50 percent of the time. The measure I1(r, t) is a spatial
analog of the Simpson’s Index.
The actual analysis of I1(r, t) is quite technical so we will leave the details to the
Appendix for interested readers. However, here we will provide some intuition for
our approach, and also provide some graphs demonstrating the dependence of I1 on
parameters and time. We will also provide some comparisons between our analysis
(based on the mesoscopic model approximation) and simulations of I1 in the full
cell-based stochastic evolutionary model.
Idea behind calculation. Let a, b be the positions of two cell samples taken at
time t0 and assume that ‖a − b‖ = r. Define Dab as the event that the cells at
positions a and b are genetically different at time t. Calculations in sections B.1 and
B.2 of the Appendix demonstrate that P(Dab) only depends on the distance between
the samples ‖a− b‖, as long as cdt+ r  L. Thus, conditioning on the location of
a and b we can conclude that I1(r, t) = 1− P(Dab).
Next we discuss the idea behind calculating P(Dab). Recall that if two clones
meet, then each continues to spread in all directions away from the interacting clone.
We will denote a cell in position x at time t by the coordinate (x, t). Va(t0) and
Vb(t0) are the space-time regions in which a mutation can influence the genetic state
of the samples at a and b, respectively. The union of these regions (Va(t0) ∪ Vb(t0))
represents the space-time region in which mutations can influence the genetic state
of the samples examined at locations a or b at time t0. Let E(A) be the number of
mutations that occur in a region A and Ek the event {E(Va(t0)∪Vb(t0)) = k}. Then,
the event Dab can be divided into sub-events according to how many mutations have
occurred in the spacetime region Va(t0) ∪ Vb(t0)
P(Dab) =
∞∑
i=1
P(Dab ∩ Ei)
The following simple calculation demonstrates that the probability of more than
two type-1 mutations occurring in the region Va(t0)∪Vb(t0) is small for the carcino-
genesis setting. First, we note that the volume |Va(t0)∪Vb(t0)| is bounded above by
|Va(t0)| + |Vb(t0)|. In 1D this sum of volumes is c1(s)t20 and in 2D it is 2pi3 c2(s)2t3o,
where c1(s) and c2(s) are the spreading speeds of the single mutant clones in di-
mensions 1 and 2 respectively, provided in Section 2. Since type-1 mutations arrive
into Va(t0) ∪ Vb(t0) as a Poisson process with rate u1s, the number of mutations in
Va(t0) ∪ Vb(t0) is stochastically dominated by a Poisson random variable with rate
λ = u1s
2t20 in 1D and
λ = u1st
3
0
4pis
log(1/s)
2pi
3
in 2D. We note that t0 is a time prior to carcinogenesis when premalignant tissue
is sampled, and in our model tumor initiation occurs at time σ2 when the first
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successful cell with two mutations arises. In [8] we found that the appropriate time
scale of this process is 1/Nu1s. Replacing t0 by this in the Poisson rate λ in each
dimension we obtain λ ≡ 2/N2u1 in 1D and λ ≡ 8pi23N3u21s log(1/s) in 2D.
We assume the point mutation rate in healthy tissue is within the range of
10−7 to 10−10 per base pair per cell division [22, 23, 24]. Selection advantages are
more difficult to ascertain experimentally but one study has estimated the average
advantage s to be approximately 0.001 [25]. Lastly, the cell population sizes of
interest in tissues at risk of initiating cancer are in the range of 106 and upward.
Using these estimates we can easily calculate that the probability of more than two
mutations arriving within the region of interest is negligible across all reasonable
parameter ranges. Thus we can approximate P(Dab) with the first two terms of the
sum above:
P(Dab) ≈ P(Dab ∩ E1) + P(Dab ∩ E2). (8)
The exact calculations for these quantities P(Dab∩E1) and P(Dab∩E2) are provided
in the Section B.1 and B.2 of the Appendix.
Agreement with microscopic model simulations. To verify our results we sim-
ulated the full cell-based stochastic evolutionary model and compared the spatial
measure I1(r, t) with our derivations from the previous section. Table 1 shows the
results of these comparisons. Since the cell-based model is very computationally
intensive, only 100 simulations were performed in each set of parameter values;
however the Wald confidence intervals are provided for each set of simulations. In
this table we see a close agreement between our theoretical values for I1 based on
the mesoscopic model and the simulations of I1 based on the microscopic model.
For all cases, N = 10000 and r = 10.
Table 1: Comparison of I1(r, t) between theory and simulation of the cell-based
stochastic model.
u1 s t Theory I1(r, t) Simulation I1(r, t) 95% CI
0.001 0.01 30 0.98 0.97 (0.94, 1)
0.001 0.01 40 0.96 0.92 (0.87, 0.97)
0.001 0.01 50 0.94 0.9 (0.84, 0.96)
0.001 0.01 60 0.90 0.9 (0.84, 0.96)
0.001 0.01 70 0.88 0.83 (0.76, 0.90)
0.0001 0.1 30 0.9 0.95 (0.91, 0.99)
0.0001 0.1 40 0.84 0.91 (0.85, 0.97)
0.0001 0.1 50 0.8 0.84 (0.77, 0.91)
0.0001 0.1 60 0.79 0.8 (0.72, 0.88)
In Figures 2 and 3 we demonstrate how the spatial measure of heterogeneity
varies in time for different parameters. In Figure 2 we observe that as time in-
creases I1(r, t) decreases; this reflects the clonal expansion of existing mutant fam-
ilies leading to an increase in heterogeneity over time. In addition, as the distance
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r increases the probability of the two samples being genetically the same decreases,
as expected. Figure 3 shows this result as a function of u1. As the mutation rate
increases, I1(r, t) decreases since the heterogeneity of the tissue increases with more
mutant clones emerging. In both figures we see that sensitivity of I1 to parameter
changes increases as r increases. This is natural since the likelihood that two cells
are identical is more likely to be altered the further apart the two cells are.
100 200 300 400 5000.8
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1
Sampling Time (t0)
I 1
 
 
r=2
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r=30
Figure 2: I1 in 2D as a function of sampling time t0. We vary the sampling radius
r and set s = 0.01 and u1 = 1e− 5, so the mutation rate is 1e− 7. We also set the
mutant growth rate cd = 0.25.
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Figure 3: I1 in 2D as a function of u1, which contributes to the mutation rate.
Mutations arise according to a Poisson process with rate u1s, and we set s = 0.01
We vary the sampling radius r and set the sampling time t0 = 300 and the mutant
growth rate cd = 0.25.
4.2 Spatial measure I2: extent of a premalignant lesion
Next, suppose we have obtained a premalignant (type-1) biopsy at a single point in
the tissue at time t. We would like to estimate the expected size of the correspond-
ing clone. In particular we define I2(r, t) to be the probability that an arbitrarily
sampled cell at distance r is from the same clone as the original sample.
In order to study I2 it is necessary to define the concept of ‘size-biased pick’
from a sequence of random variables {Xi}i≥1.
Definition 1. A size-biased pick from the sequence (Xi) is a random variable X[1]
such that
P
(
X[1] = Xi
∣∣ X1, . . . Xn) = Xi
X1 + . . .+Xn
.
Suppose that by time t there have been successful mutations at space time points
{(xi, ti)}Ni=1 initiating populations C1,i, 1 ≤ i ≤ N . In the model description we
stated that the assumptions (A0)-(A3) hold throughout the paper. A consequence
of these assumptions, proved in Theorem 4 of [8], is that overlaps between distinct
type-1 cell is unlikely. Thus we assume here that 1 ≤ i ≤ N , C1,i = Bxi,cd(t−ti).
In order to calculate I2, we first choose a clone C[1] via size biased pick from the
different clones {C1,i}. The radius of this pick is denoted R[1]. For ease of notation
we will make the following substitution throughout the rest of the section C = C[1]
and R = R[1]. We next choose a point, p1, at random from the picked clone C. We
choose a second point p2, at random a distance r away from p1. In other words, the
point p2 is chosen at random from the circle
S = {x ∈ R2 : |x− p1| = r}.
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To calculate I2 we are interested in determining the probability that p2 is contained
in C. More specifically, let us denote the center of C by xo. It is useful to define
X = |p1−xo| which is a random variable with state space [0, R]. The heterogeneity
measure I2(r, t) is given by:
I2(r, t) ≡ P (p2 ∈ C) = E [P (p2 ∈ C|R,X)] . (9)
The following two properties are useful in determining I2:
(i) If X + r ≤ R then S ⊂ C. To see this consider z ∈ S then
|z − xo| = |z − p1 + p1 − xo| ≤ |z − p1|+ |p1 − xo| ≤ r +X ≤ R.
(ii) If R +X < r then S ∩ C = ∅. To see this take z ∈ C which of course implies
|z − xo| ≤ R and thus
|z − p1| = |z − xo + xo − p1| ≤ R+X < r.
We then have that
P (p2 ∈ C|R,X) =

0, R+X < r
1, X + r ≤ R
φ(X,R), otherwise.
(10)
We can use the cosine rule to see that
φ(X,R) =
1
pi
cos−1
(
X2 + r2 −R2
2Xr
)
. (11)
Substituting expressions (10) and (11) into (9) results in a formula for I2 that can
be easily approximated via Monte Carlo simulation. Details of this procedure are
provided in Appendix C.
The heterogeneity measure I2 is designed to be an estimate of the extent of a
premalignant lesion that has already been detected via one point biopsy. Thus it is
of interest to determine the value of I2 at the time of detection of the premalignant
condition (which itself may be random). We hypothesize that detection of the
premalignancy may occur at a random time τ which occurs with a rate proportional
to the total man-hours of premalignant lesions. In other words, detection of the
condition is driven by the size and duration of premalignant lesion presence. Let us
define τ with the following:
P (τ > t) = E exp
(
−µ
∫ t
0
|χt|dt
)
, (12)
where we recall that |χt| is the volume of type-1 cells at time t. Display (12) tell
us that detection occurs at rate µ. Note we assume that (A1-A3) hold with u2s
replaced by µ.
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In Section C of the Appendix we also develop a numerical approach for estimat-
ing I2 at the random detection time τ . Interestingly enough, it is computationally
easier to compute I2(r, τ) than I2(r, t).
Numerical examples. In Figure 4, I2(r, t) is plotted as a function of r for various
values of u1, s and t. Figure 5 shows analogous plots of I2(r, τ) at the random
detection time. Comparing Figures 4 and 5 we observe an interesting phenomenon.
In particular when looking at I2 at a fixed time in Figure 4 we see that for each r and
t, I2 is an increasing function of both u1 and s. This makes sense if we consider the
system at a fixed time. Then increasing the mutation rate will increase the expected
growing time of any clones, i.e., they are more likely to be born earlier; therefore any
clone we select is likely to be larger, so it is more likely that the second point selected
a distance r away will be in the original clone. Similarly increasing s increases the
expected size of clones present at time t, and thus increases I2(r, t). However,
when we look at Figure 5 we see that I2(r, τ) is decreasing in u1. Interestingly by
observing the process at the random time τ we flip the dependence on the parameters
u1. This phenomenon results from the fact that increasing the mutation rate allows
for detection to be caused by multiple clones, which will therefore be smaller at
detection than if the detection were driven by a single clone.
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Figure 4: Plot of I2(r, t) in 2D as a function of sampling radius for (A) varying
selection strength, s, (B) varying u1, and (C) varying t. In all panels N = 2e5 and
1e4 Monte Carlo simulations are performed. Unless varied, s = 0.1, u1 = 7.5e − 7
and t is the median of the detection time τ with µ = 2e− 6.
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Figure 5: Plot of I2(r, τ) in 2D as a function of sampling radius. In panel (A) we
vary the selection strength, s and in panel B we vary u1. In all panels N = 2e5,
we use 1e4 Monte Carlo simulations and for the random detection time τ we use
µ = 2e− 6. If not mentioned we set s = 0.1, u1 = 7.5e− 7.
5 Discussion
In this work we have analyzed and examined several measures of heterogeneity in a
spatially structured model of carcinogenesis from healthy tissue. In particular, we
first derived estimates of the traditionally nonspatial measure of diversity, Simpson’s
Index, in the premalignant tissue and studied how the Simpson’s Index changes in
time and varies with parameters. We observed that as expected, the Simpson’s
Index decreases over time as more mutants are produced, and that this process
occurs faster in a higher mutation rate setting. The effect of selection overall is also
to speed up this process. We also formulated and analyzed two spatially-dependent
measures of population heterogeneity, motivated by clinical questions. In particular
we analyzed a measure (I1) that can identify the length scale of genetic heterogeneity
during the carcinogenesis process as well as a measure (I2) that can estimate extent
of a surrounding premalignant clone given a premalignant point biopsy.
We note that in this work we have confined our analysis to a two-step model
of carcinogenesis. The results can be used in a setting where more genetic hits are
required for full malignant transformation. However our heterogeneity estimates
would apply to the population of cells with a single mutation and thus can be used
in the setting of early stages of carcinogenesis only. Work on further mutations will
be the subject of future work.
These analyses facilitate a better understanding of how to interpret discrete (in
both time and space) samples from a spatially evolving population during carcino-
genesis. For example, the quantity I2 can be calculated to help determine the ex-
pected size of a premalignant lesion, given a point biopsy that is premalignant. In ad-
dition the quantity I1 may be used to generate suggestions for optimal sample spac-
ing in situations where multiple biopsies or samples are possible. Finally, we note
that although it is possible to calculate these diversity indices using computational
simulation of similar cell-based or agent-based models, it can be extremely computa-
tionally onerous to simulate such models for even small sized lattices (100x100 sites)
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for a lengthy period of time such as during the process of carcinogenesis. Therefore
the heterogeneity estimates we derive based on our mesoscopic model in many cases
provide the only feasible way to estimate spatial diversity in models living on a larger
lattice e.g., 1000x1000 sites or larger. Given the large number of epithelial cells in a
small area, realistic simulations to determine statistical properties of diversity mea-
sures during carcinogenesis may be completely infeasible. Our results here provide
analytical or rapidly computable expressions that enable a detailed assessment of
how these heterogeneity measures vary depending on time as well as tissue/genetic
parameters such as mutation rate and selective advantage conferred by the genetic
alteration. These tools can be utilized to study how tissue heterogeneity in prema-
lignant conditions varies between sites and tissue types, and thus guide sampling or
biopsy procedures across various cancer types.
A Details for non-spatial Simpson’s Index
A.1 Preliminary definitions and results
To characterize the distributions of the Simpson’s Index, we introduce two defini-
tions. Let L1, L2, . . . , Ln be independent, identically distributed random variables
with distribution F . Recall the definition of a sized-biased pick from Definition 1 in
Section 4.2. Then we define a size-biased permutation as follows.
Definition 2. We call
(
L[1], . . . L[n]
)
a size-biased permutation (s.b.p) of the se-
quence (Li) if L[1] is a size-biased pick of the sequence, and for 2 ≤ k ≤ n and
P
(
L[k] = Lj
∣∣ L[1], . . . , L[k−1];L1, . . . Ln) = Lj 1(Lj 6=L[i],∀1≤i<k)
L1 + . . .+ Ln −
(
L[1] + . . .+ L[k−1]
) .
The following results will be useful.
Proposition A.1. (Proposition 2 in [26]) For 1 ≤ k ≤ n, let νk be the density of
Sk, the sum of k i.i.d random variables with distribution F . Then
P
(
X[1] ∈ dx1, . . . , X[k] ∈ dxk
)
=
n!
(n− k)!
 k∏
j=1
xjν1(xj)dxj
 . . .
. . .
∫ ∞
0
νn−k(s)
k∏
j=1
(xj + . . .+ xk + s)
−1 ds. (13)
Corollary A.2. (Corollary 3 in [26]) Let Tn−k = X[k+1] + . . . + X[n] denote the
sum of the last n− k terms in an i.i.d s.b.p of length n. Then for k = 1, . . . , n− 1,
P (Tn−k ∈ ds | Tn−k+1 = t) = (n− k + 1) t− s
t
ν1(t− s) νn−k(s)
νn−k+1(t)
ds. (14)
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A.2 Conditional expectation
Recalling that type 1 clones have a linear radial growth rate, Simpson’s index (4)
can be rewritten explicitly
R(t) =
Nt∑
i=1
[
(1− ti/t)d∑Nt
j=1 (1− tj/t)d
]2
, (15)
where {ti}Nti=1 are the points of a Poisson process with constant intensity Nu1st. In
particular, we note that conditioned on Nt, the ti are i.i.d and
(t1/t|Nt) ∼ U(0, 1).
We define now Xi := (1− ti/t)d+1 and let
T :=
Nt∑
i=1
Xi, (16)
which allows us to rewrite (15) as
R(t) =
Nt∑
i=1
(
Xi
T
)2
. (17)
Note that conditioned on Nt, the Xi are i.i.d with
(X1|Nt) ∼ Beta
(
1
d
, 1
)
.
To see this, note first that by symmetry Xi ∼ (ti/t)d; using characteristic functions,
it is then easy to verify that for X ∼ Beta (α, 1) and Y ∼ U(0, 1), we have X ∼ Y n
if and only if α = 1/n. Using the above notation and recalling the notion of a
size-biased pick in Definition 1, we condition (17) on Nt to find
(R(t) | Nt = n) =
n∑
i=1
Xi
T
P
(
X[1] = Xi|X1, . . . , Xn
)
=E
(
X[1]
T
∣∣∣∣ X1, . . . , Xn) . (18)
To compute the conditional expectation of Simpson’s Inded R(t), we take the
expectation of (18) to find
E (R(t) | Nt = n) = E
(
X[1]
T
)
=
∫ ∞
0
∫ ∞
0
( r
x
)
P
(
X[1] ∈ dr, T ∈ dx
)
. (19)
Setting k = 1, it follows now from Corollary A.2
E (R(t) | Nt = n) =
∫ ∞
0
∫ ∞
0
( r
x
)
P (Tn−1 ∈ d(x− r), T ∈ dx)
=
∫ ∞
0
∫ ∞
0
( r
x
)
P(T ∈ dx)P (Tn−1 ∈ d(x− r) | T = x)
=n
∫ ∞
0
∫ ∞
0
( r
x
)2
ν1(r) νn−1(x− r) dxdr. (20)
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Note that the support of ν1 is over [0, 1], and the support of νn−1 is over [0, n]. Now,
by definition, ν1 is the pdf of Beta
(
1
d , 1
)
, i.e.
ν1(x) =
1
d
x
1
d
−1.
On the other hand, νn−1 is the density of the sum of n− 1 i.i.d. Beta(1d , 1) random
variables, i.e.
νn−1(x) =
(
ν
∗(n−1)
1
)
(x).
For positive integer n let Sn = B1+. . .+Bn where Bi are independent Beta(
1
d , 1)
random variables. Finally, from (20) we find
E[R(t)|Nt = n] = nE
[(
S1
Sn
)2]
, (21)
Sn := B1 + . . .+Bn where Bi are independent Beta(
1
d , 1) random variables.
A.3 Upper bound for variance
We derieve an upper bound for the variance of the conditional Simpson’s Index as
follows:
[E (R(t) | Nt = n)]2 ≤E
(
R2(t)
∣∣ Nt = n) = E([E(X[1]
T
∣∣∣∣ X1, . . . , Xn)]2
∣∣∣∣∣ Nt = n
)
≤E
(
E
([
X[1]
T
]2 ∣∣∣∣∣ X1, . . . , Xn
) ∣∣∣∣∣ Nt = n
)
=E
([
X[1]
T
]2 ∣∣∣∣∣ Nt = n
)
=n
∫ ∞
0
∫ ∞
0
( r
x
)3
ν1(r) νn−1(x− r) dx dr, (22)
where the second to last equality follows from the fact that the sub-sigma algebra
σ(Nt = n) is coarser than σ(X1, . . . , Xn).
A.4 Proof of Proposition 3.3
Proof. Let Yn = (R(t)|N(t) = n), and note that by definition Yn ≥ 0. Thus it
suffices to show that E[Yn]→ 0 as n→∞. Note that
E[Yn] =
1
n
E
[(
S1
Sn/n
)2]
,
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and by the law of large numbers S1/(Sn/n) → S1/E[B1] as n → ∞. Thus if we
establish that
sup
n<∞
E
[(
S1
Sn/n
)3]
<∞, (23)
then by uniform integrability we will have E[(S1/(Sn/n))2]→ 1, and thus E[Yn]→ 0.
In order to establish (23) define S2,n = B2 + . . .+Bn and for ε > 0 the event
An = {S2,n > (1− ε)(n− 1)E[B1]}.
We then have that
E
[(
S1
Sn/n
)3]
= n3E
[(
S1
S1 + S2,n
)3]
= n3E
[(
S1
S1 + S2,n
)3
;An
]
+ n3E
[(
S1
S1 + S2,n
)3
;Acn
]
≤ O(1) + n3P(Acn).
From Azuma-Hoeffding inequality we know that there exists a k independent of n
such that P(Acn) ≤ e−kn, thus establishing (23). 
A.5 Monte Carlo Simulations
We evaluate the conditional expectation of Simpson’s Index for fixed time t using
Monte Carlo simulations. Based on the representation in (5), we first generate M
independent copies of the vector (S1, Sn) denoted by {(S(i)1 , S(i)n )}Mi=1, and form the
estimator
µˆ(n,M) =
n
M
M∑
i=1
(
S
(i)
1
S
(i)
n
)2
,
which satisfies E[µˆ(n,M)] = E[R(t)|Nt = n] and V ar[µˆ(n,M)] = O(1/M). If we
simulate M1 copies of Nt, denoted by {N (i)t }M1i=1 and then for each realization Nt = n
we form the estimator µˆ(n,M2) then we have an unbiased estimator of E[R(t)] via
Rˆ(M1,M2) =
1
M1
M1∑
j=1
∞∑
n=0
1{N(j)t =n}
µˆ(n,M2),
since N
(j)
t is independent of µˆ(n,M2). Note that simulating the mesoscopic model M
times and averaging R(t) over those simulations is equivalent to using the estimator
Rˆ(M, 1).
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B I1 Calculations
Recall from Section 4.1 that I(r, t) is approximated by (8). It is therefore necessary
to calculate P(Dab ∩E1) and P(Dab ∩E2). Also recall that Vx(t0) is the space-time
cone centered at x and has radius cdt0 at time 0 and radius 0 at time t0. For two
points a and b in our spatial domain we will be interested in the sets
D(r, t0) = Va(t0)∆Vb(t0)
M(r, t0) = Va(t0) ∩ Vb(t0),
where r = ‖a−b‖. We suppress the dependence on a and b in D and M to emphasize
that the volume of these sets depends only on the distance ‖a − b‖. Denote the
Lebesgue measure of a set A ∈ Rd × [0,∞) by |A|. In order to calculate I(r, t) it
will be necessary to compute |D(r, t0)| and M(r, t0)|. Note that
|D(r, t0)| = 2 (|Va(t0)| − |M(r, t0)|) . (24)
In the next two subsections we compute I1 in one and two dimensions. For ease of
notation we define µ = u1s. For real number a define a
+ = max{a, 0}.
B.1 I1 in 1 dimension
We will first calculate the volumes |Va(t0)|, |M(r, t0)|, and from (24) |D(r, t0)|. In
one dimension these calculations are simple: |Vx(t0)| = t20cd, and |M(r, t0)| =
[(2t0cd−r)+]2
4cd
, so we have that:
D(r, t0) = 2t
2
0cd −
2[(2t0cd − r)+]2
4cd
.
Note that if t0 < r/(2cd) then the only way sites a and b are the same at time t0 is
if there are zero mutations in Va(t0) ∪ Vb(t0), i.e.,
I(r, t0) = exp (−µ|Va(t0) ∪ Vb(t0)|) = exp
(−2µt20cd) .
Thus assume for the remainder of the subsection that t0 > r/(2cd), in which case
|Va(t0) ∪ Vb(t0)| = 2t20cd −
(2t0cd − r)2
4cd
.
And since the mutations arise according to a Poisson process with parameter µ,
P(Ek) =
(µ|Va(t0) ∪ Vb(t0)|)ke−µ|Va(t0)∪Vb(t0)|
k!
.
From (8) it thus remains to compute P (Dab|E1) and P (Dab|E2). Note that if
event E1 occurs then Dab can only occur if the single mutation occurs in the set
D(r, t0) and therefore
P(Dab|E1) = |D(r, t0)||Va(t0) ∪ Vb(t0)| = 1−
(2t0cd − r)2
8t20c
2
d − (2t0cd − r)2
.
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Figure 6: Regions
In order to calculate P(Dab|E2), we must split Va(t0) ∪ Vb(t0) into 7 different
regions because the probabilities will differ, depending on where the first mutation
occurs (as shown in Figure 6). By conditioning on E2 we assume that two mutations
occur in the space-time region Va(t0)∪Vb(t0). Denote the space time coordinates of
the first mutation by (x1, t1).
If (x1, t1) occurs outside of M(r, t0) but between a and b (i.e. in regions R6
or R7), then the cells will definitely be different, regardless of where the second
mutation occurs. However, if the first mutation occurs in Ri, 1 ≤ i ≤ 5, then
the location of the second mutation will determine whether the sampled cells are
different. Thus each region Ri, 1 ≤ i ≤ 5, will have an associated region Zi that will
be used to calculate P(Dab|E2). If the first mutation occurs at the point (x1, t1) ∈ Ri,
then the shape and size of Zi(x1, t1) depends on i and (x1, t1).
First, we will consider the regions inside M(r, t0), which are R1, R2, and R3.
For i = 1, 2, 3, Zi(x1, t1) represents the region in which the occurrence of a second
mutation would make the sampled cells different at time t0, i.e. the two clones will
meet between a and b and then will each spread to one of the cells.
If (x1, t1) ∈ R1, then (x1, t1) is in M(r, t0) and between a and b. In this case,
Z1(x1, t1) consists of two triangles, whose upper vertices occur at positions a and b
(see Figure 7a). The base of the triangle on the left is 2(x1−a), and the base of the
triangle on the right is 2(b − x1), so the total area of Z1(x1, t1) is c−1d [(x1 − a)2 +
(b− x1)2].
If (x1, t1) ∈ R2, then (x1, t1) is in M(r, t0) but to the left of a. In this case,
Z2(x1, t1) is a trapezoidal region. This trapezoidal region can be constructed by
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Figure 7: The region in which the occurrence of a second mutation would make the
cells located at a and b different.
1
a b
x1
t
4Z
Figure 8: Z4(x1, t1): The region in which the occurrence of a second mutation would
make the cells located at a and b the same.
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taking the triangle whose upper vertex is at position b and subtracting the smaller
triangle with upper vertex at position a (see Figure 7b). The base of the larger
triangle is 2(b − x1), and the base of the smaller triangle is 2(a − x1). Hence, the
area of Z2(x1, t1) is c
−1
d [(b− x1)2 − (a− x1)2]. Z3(x1, t1) is constructed analogously
to Z2(x1, t1).
Z4(x1, t1) and Z5(x1, t1) have a slightly different meaning. Given that the first
mutation occurs in region 4 or 5, respectively, Z4(x1, t1) and Z5(x1, t1) each represent
the region in which the occurrence of a second mutation would make the sampled
cells the genetically identical.
If (x1, t1) ∈ R4, then (x1, t1) is outside of M(r, t0) and to the left of a. In
order for a and b to be the same in this case, the second clone must meet the first
clone before it reaches a, and the second clone must spread to b before t0. Hence,
Z4(x1, t1) is a triangle inside M(r, t0) (see Figure 8). In the next paragraph we will
explain how the area of Z4(x1, t1) is calculated.
The distance between the right vertex of Z4(x1, t1) and a is equal to the distance
between a and x1, so the position of that vertex is a + (a − x1) = 2a − x1. Let V ′b
be the portion of Vb that falls between the t-values t1 and t0. Then we can find
the position of the left vertex of Z4(x1, t1) by considering it as the left corner of V
′
b .
The height of V ′b is t0 − t1, so its base is 2cd(t0 − t1). Then the left vertex of V ′b ,
and consequently the left vertex of Z4(x1, t1) is b − cd(t0 − t1). Hence, the base of
Z4(x1, t1) has length 2a− x1 − b+ cd(t0 − t1). Therefore, the area of Z4(x1, t1) is:
(2a− x1 − b+ cd(t0 − t1))2
4cd
.
Analogously, the area of Z5(x1, t1) is:
(a− 2b+ x1 + cd(t0 − t1))2
4cd
.
In summary, we have the following areas:
If (x1, t1) ∈ R1, then |Z1(x1, t1)| = c−1d [(x1 − a)2 + (b− x1)2]
If (x1, t1) ∈ R2, then |Z2(x1, t1)| = c−1d [(b− x1)2 − (a− x1)2]
If (x1, t1) ∈ R3, then |Z3(x1, t1)| = c−1d [(x1 − a)2 − (x1 − b)2]
If (x1, t1) ∈ R4, then |Z4(x1, t1)| = (2a− x1 − b+ cd(t0 − t1))
2
4cd
If (x1, t1) ∈ R5, then |Z5(x1, t1)| = (a+ cd(t0 − t1)− 2b+ x1)
2
4cd
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Let Xn be the position of the nth mutation. Then:
P(Dab|E2) =
3∑
i=1
P(X2 ∈ Zi|X1 ∈ Ri)P(X1 ∈ Ri)
+
5∑
i=4
P(X2 /∈ Zi|X1 ∈ Ri)P(X1 ∈ Ri) +
7∑
i=6
P(X1 ∈ Ri).
Thus to calculate P(Dab) it remains to calculate P(X2 ∈ Zi|X1 ∈ Ri) and P(X1 ∈ Ri)
for i ∈ {1, . . . , 5}.
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Figure 9: The region inside Va∪Vb that is affected by a mutation at (x, t) ∈ Ri, and
thus is not susceptible to subsequent mutation.
Let Ai(x, t) be the region inside Va∪Vb that is affected by a mutation at (x, t) ∈
Ri. Since type-1 mutations must occur in cells that have not yet mutated, the
second type-1 mutation cannot occur inside Ai(x, t).
The area of Ai(x, t) depends on whether (x,t) is in M(r, t0), Va\Vb, or Vb\Va. The
following are the areas |Ai(x, t)|, which will be used to calculate P(X2 ∈ Zi|X1 ∈ Ri):
|A1(x, t)| = |A2(x, t)| = |A3(x, t)| =
cd(t0 − t+ r
2cd
)2 − 2r
2 + (b− x+ cd(t0 − t))2 + (x− a+ cd(t0 − t))2
4cd
|A4(x, t)| = |A6(x, t)| = cd(t0 − t)2 − (x− a+ cd(t0 − t))
2 + (a− x+ cd(t0 − t))2
4cd
|A5(x, t)| = |A7(x, t)| = cd(t0 − t)2 − (x− b+ cd(t0 − t))
2 + (b− x+ cd(t0 − t))2
4cd
.
We will explain how |A4(x, t)| is calculated and leave out the calculations for
|A1(x, t)| and |A5(x, t)|, which can be done similarly.
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|A4(x, t)| is calculated by taking the area of the truncated triangle V ′a (the por-
tion of Va that lies between times t and t0) and then subtracting the area of two
smaller triangles that are not in A4 (see Figure 9b). The bases of these triangles lie
along line t, between x and the two lower vertices of V ′a. The height of V ′a is t0−t, so
the base is 2cd(t0− t). Hence the lower left vertex of V ′a is at position a− cd(t0− t),
and the lower right vertex of V ′a is at position a+cd(t0−t). Therefore the base of the
left small triangle is x− a+ cd(t0− t), so its area is (x− a+ cd(t0 − t))
2
4cd
. The base
of the right small triangle is a + cd(t0 − t) − x, so its area is (a− x+ cd(t0 − t))
2
4cd
.
Since |V ′a| = cd(t0 − t)2, we get the area listed above for A4 and A6.
If X1 = (x, t) ∈ Ri, then P(X2 ∈ Zi) = |Zi(x, t)||Va ∪ Vb \Ai(x, t)| . We can integrate
this quantity over the places where the first mutation could have occurred, which is
all of Ri, and then divide by |Ri| to get:
P(X2 ∈ Zi|X1 ∈ Ri) = 1|Ri|
∫
Ri
|Zi(x, t)|
|Va ∪ Vb \Ai(x, t)|dxdt.
Now it remains to calculate P(X1 ∈ Ri). Since mutations arrive according to a
Poisson process, we have P(X1 ∈ Ri) = µ(|Ri|)e−µ(|Ri|), and it suffices to know the
following areas:
|R1| = (2t0cd − r)
2
4cd
− (a− b+ cdt0)
2
2cd
|R2| = |R3| = (a− b+ cdt0)
2
4cd
|R4| = |R5| = cdt
2
0
2
− (a− b+ cdt0)
2
4cd
|R6| = |R7| = r
2
4cd
.
The expression for |R2| listed above is calculated by considering R2 as a triangle
inside Vb. The height of Vb is t0, so the left vertex is at position b− cdt0. Then the
base of R2 is a− b+ cdt0, which means its area is (a− b+ cdt0)
2
4cd
.
Then we can use |R2| to calculate |R1| and |R6|:
|R1| = |M(r, t0)| − 2|R2|, and |R4| = 12 |Va| − |R2|. And the height of R6 is t0
minus the height of R2, so |R6| simplifies to r
2
4cd
.
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All of the equations above can be used to calculate P(Dab):
P(Dab) ≈P(Dab|E1)P(E1) + P(E2)
( 3∑
i=1
P(X2 ∈ Zi|X1 ∈ Ri)P(X1 ∈ Ri)
+
5∑
i=4
P(X2 /∈ Zi|X1 ∈ Ri)P(X1 ∈ Ri) +
7∑
i=6
P(X1 ∈ Ri)
)
.
B.2 I1 in 2 dimensions
Similary to the one dimensional case, we will first calculate |Va(t0)| and |M(r, t0)|.
In the two dimensional setting this is slightly more difficult. First we know that
|Va(t0)| = pit30c2d/3, so it remains to find |M(r, t0)|.
r/2θ
x
cd(t− s)
Figure 10: Overlap of space time cones at time s.
First observe that if r > 2cdt0 then M(r, t0) = ∅, so we only need to calculate
|M(r, t0)| in the case r < 2cdt0. If we consider the overlap of space-time cones at
the fixed time s ∈ [0, t0 − r/(2cd)] then looking at Figure 10 it can be seen that
half the area of the overlap of their cones at this specific time is given by taking the
difference between the area of the circular section with radius cd(t− s) and angle θ
and twice the area of the triangle with side lengths x, r/2, cd(t0 − s). The area of
the circular section is given by
c2d(t0 − s)2 cos−1
(
r
2cd(t0 − s)
)
,
and twice the area of the triangle is given by
r
2
√
c2d(t0 − s)2 − r2/4.
Thus the area of overlap between the two cones at time s is given by
a(s) = 2
(
c2d(t0 − s)2 cos−1
(
r
2cd(t0 − s)
)
− r
2
√
c2d(t0 − s)2 − r2/4
)
.
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The space-time volume of M(r, t) is therefore given by
|M(r, t0)| =
∫ t0−r/2cd
0
a(s)ds
=2
∫ t0−r/2cd
0
(
c2d(t0 − s)2 cos−1
(
r
2cd(t0 − s)
)
− r
2
√
c2d(t0 − s)2 − r2/4
)
ds
=
2
cd
∫ cdt0
r/2
y2 cos−1
(
r
2y
)
dy − r
cd
∫ cdt0
r/2
√
y2 − r2/4 dy.
Applying integration by parts to the first integral we see that
2
cd
∫ cdt
r/2
y2 cos−1
(
r
2y
)
dy =
2c2dt
3
0
3
cos−1
(
r
2cdt0
)
− r
3cd
∫ cdt0
r/2
y2√
y2 − r2/4dy.
We thus have that
|M(r, t0)| =2c
2
dt
3
0
3
cos−1
(
r
2cdt0
)
− r
6cd
∫ cdt0
r/2
16y2 − 3r2√
4y2 − r2dy
=
2c2dt
3
0
3
cos−1
(
r
2cdt0
)
− rt0
3
√
4c2dt
2
0 − r2 −
r3
12cd
log
 r
2cdt0 +
√
4c2dt
2
0 − r2
 ,
which we can combine with (24) to see that for r < 2cdt0
|D(r, t)| = 2c
2
dt
3
0
3
(
pi − 2 cos−1
(
r
2cdt0
))
+
2rt0
3
√
4c2dt
2
0 − r2
+
r3
6cd
log
 r
2cdt0 +
√
4c2dt
2
0 − r2
 .
With these calculations we see that
|Va(t0) ∪ Vb(t0)| = 2c
2
dt
3
0
3
(
pi − cos−1
(
r
2cdt0
))
+
rt0
3
√
4c2dt
2
0 − r2
+
r3
12cd
log
 r
2cdt0 +
√
4c2dt
2
0 − r2
 ,
We can now explicitly calculate P(Dab|E1) = |D(r,t0)||Va(t0)∪Vb(t0)| . The remainder of this
section will deal with the calculation of P(Dab|E2).
The approach here will be slightly different from the one-dimensional case be-
cause it is easier to look at the two-dimensional cross sections of |Va(t0) ∪ Vb(t0)|,
rather than the entire three-dimensional space-time cones. Therefore, we will split
the cross sections into just two regions, and then when calculating the relevant vol-
umes involved in I2, we will split the regions into multiple cases. In the end, the
27
a 
b
 
2
m1
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Figure 11: When two mutation circles collide, they will continue to expand along
the line perpendicular to the line segment joining the two mutation origins.
process is similar, but the setup will be simpler, and then the volume calculations
will be more complicated in the two-dimensional setting.
If two events occur in Va(t0)∪Vb(t0), then the probabilities will differ, depending
on whether the first event occurs inM(r, t0) or inD(r, t0). We will assume that if two
mutation circles collide, then we can draw a line through that point, perpendicular
to the line segment connecting the two mutations (as show in Figure 11). The circles
will not extend beyond that line but will continue to expand in all other directions.
  
ra rb
a b
Figure 12: The cross-section of the cones Va(t0), Vb(t0), Ca(t1), and Cb(t1) at the
moment when a mutation occurs in the intersection, M(r, t0). If a second mutation
occurs in the shaded mutation, then the cells located at a and b will be different.
If the first event occurs in M(r, t0) at position (x1, y1) at time t1, then let ra
be the distance between (x1, y1) and a, and let rb be the distance between (x1, y1)
and b. Then let Ca(t1) be the cone centered at a that extends to the edge of the
expanding clone, so Ca(t1) will have radius ra at time t1 and radius 0 at time
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(t1 +
ra
cd
). Similarly, Cb(t1) will be the cone centered at b with radius rb at time t1
and radius 0 at time (t1 +
rb
cd
). Cross-sections of these cones are shown in Figure 12.
If the second mutation occurs outside of Ca(t1)∪Cb(t1), then the first clone will
reach both a and b before interacting with the second clone. If the second mutation
occurs in Ca(t1) \ Cb(t1), then the line dividing the two clones will separate a from
b, so the second clone will affect a, and the first will affect b, making the two cells
different. Similarly, if the second mutation occurs in Cb(t1) \ Ca(t1), then the first
clone will affect a, and the second will affect b.
However if the second mutation occurs in Cb(t1)∩Ca(t1), then both a and b will
be on the same side of the line dividing the mutation circles, so the second clone
will affect both a and b. Therefore, the two cells will only be different if the second
mutation occurs in Cb(t1)4Ca(t1).
a b
  
ra
Figure 13: The cross-section of the cones Va(t0), Vb(t0), and Ca(t1) at the moment
when a mutation occurs in D(r, t0). If a second mutation occurs in the shaded
mutation, then the cells located at a and b will be the same.
If the first mutation occurs in D(r, t0), then its position (x1, y1) is closer to either
a or b. Without loss of generality, say that (x1, y1) is closer to a. Again let ra be
the distance between (x1, y1) and a, and let Ca(t1) be the cone centered at a with
radius ra at time t1 and radius 0 at time (t1 +
ra
cd
). A cross-section of this cone is
shown in Figure 13.
If the second mutation occurs outside of Ca(t1), then the first mutation will
reach a before interacting with the second mutation. Since the first mutation is
outside Vb(t0), it cannot reach b by time t0, so the sampled cells will be different.
If the second mutation occurs inside Ca(t) but outside M(r, t), then the two
mutations will interact before the first mutation reaches a, meaning that the second
mutation will affect a. However, the second mutation will not spread to b, since it
does not start in Vb(t0). Hence, the cells located at a and b will only be the same if
the second mutation occurs in Ca(t1) ∩M(r, t0).
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In summary, we have:
P(Dab|E2) =P(X2 ∈ Cb(t1)4Ca(t1)|X1 ∈M(r, t0))P(X1 ∈M(r, t0)) (25)
+ P(X2 /∈ Ca(t1) ∩M(r, t0)|X1 ∈ Va(t1) \ Vb(t1))P(X1 ∈ Va(t1) \ Vb(t1))
+ P(X2 /∈ Cb(t1) ∩M(r, t0)|X1 ∈ Vb(t1) \ Va(t1))P(X1 ∈ Vb(t1) \ Va(t1))
Since the mutations arise according to a homogenenous Poisson process, we can
use the volume calculations for M(r, t0) and Va(t1)\Vb(t1) to calculate the following
probabilities:
P(X1 ∈M(r, t0)) = µ(|M(r, t0)|)e−µ(|M(r,t0)|)
P(X1 ∈ Va(t1) \ Vb(t1)) = P(X1 ∈ Vb(t1) \ Va(t1)) = µ(|Va(t1) \ Vb(t1)|)e−µ(|Va(t1)\Vb(t1)|)
Similarly to the 1-D case:
P(X2 ∈ Cb(t)4Ca(t)|X1 ∈M(r, t0)) (26)
=
1
|M(r, t0)|
∫
M(r,t0)
|Cb(t)4Ca(t)|
|Va(t0) ∪ Vb(t0) \A(x, y, t)|dxdydt,
where A(x, y, t) is the cone-shaped region inside Va(t0)∪ Vb(t0) that is affected by a
mutation at (x, y, t).
In addition:
P(X2 ∈ Ca(t1) ∩M(r, t0)|X1 ∈ Va(t0) \ Vb(t0)) (27)
=
1
|Va(t0) \ Vb(t0)|
∫
Va(t0)\Vb(t0)
|Ca(t) ∩M(r, t0)|
|Va(t0) ∪ Vb(t0) \A(x, y, t)|dxdydt.
We next develop formulas to compute the volumes in the previous two displays.
Note that
|Cb(t1)4Ca(t1)| = |Cb(t1)|+ |Ca(t1)| − 2|Cb(t1) ∩ Ca(t1)|
and that |Ca(t1)| = pi
3
r2a
(
t1 +
ra
cd
)
, since Ca(t1) is a cone with radius ra and height
t1 +
ra
cd
. Similarly, |Cb(t1)| = pi
3
r2b
(
t1 +
rb
cd
)
.
We next compute |Ca(t1)∩Ca(t1)|. A cross-section of Ca(t1) has radius ra−(s−
t1)cd at time s, and a cross-section of Cb(t1) has radius rb−(s−t1)cd at time s. Ca(t1)
and Cb(t1) will have a nonempty intersection until ra−(s−t1)cd+rb−(s−t1)cd = r,
i.e. when s =
ra + rb − r
2cd
+ t1.
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If we denote the area of intersection of the cross-sections of Ca(t1) and Cb(t1)
at time s by I(s), then
|Cb(t1) ∩ Ca(t1)| =
∫ ra+rb−r
2cd
+t1
t1
I(s)ds. (28)
I(s) is calculated by summing the areas of the two circular segments, each of
which can be calculated by subtracting the area of a triangle from the area of a
wedge of the circle
I(s) = R2a(s) cos
−1
(
da(s)
Ra(s)
)
− da(s)
√
R2a(s)− d2a(s)
+ R2b(s) cos−1
(
db(s)
Rb(s)
)
− db(s)
√
R2b(s)− d2b(s),
where Ra(s) = ra − (s− t1)cd, Rb(s) = rb − (s− t1)cd, da(s) = r
2 −R2b(s) +R2a(s)
2r
,
and db =
r2 +R2b −R2a
2r
.
In order to compute the quantity |Ca(t)∩M(r, t)| used in equation 27, we need
to first determine when the time cross sections of Ca(t) and Vb(t) have nonempty
intersection. This occurs when ra − (s − t1)cd + cd(t0 − s) > r, i.e. when s <
1
2
(
ra − r
cd
+ t0 + t1
)
. Hence:
|Ca(t) ∩M(r, t)| =
∫ 1
2
( ra−r
cd
+t0+t1)
t1
Iˆ(s)ds, (29)
where
Iˆ(s) = R2a(s) cos
−1
(
dˆa(s)
Ra(s)
)
− dˆa(s)
√
R2a(s)− dˆa
2
(s)
+ Rˆb
2
(s) cos−1
(
dˆb(s)
Rˆb(s)
)
− dˆb(s)
√
Rˆb
2
(s)− dˆb2(s).
Ra is defined above, Rˆb(s) = cd(t0 − s), dˆa(s) = r
2 − Rˆb(s)2 +R2a(s)
2r
, and dˆb(s) =
r2 + Rˆb
2
(s)−R2a(s)
2r
.
We finally compute |(Va(t0)∪ Vb(t0)) \A(x, y, t)|. In pursuit of this define U1 as
the region that is affected by the mutation at (x1, y1, t1), i.e.,
U1 = {(x, y, s) : |(x, y)− (x1, y1)| ≤ cd(s− t1), t1 ≤ s ≤ t0}.
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Let u1(s) be the cross-section of U1 at time s, i.e.,
u1(s) = {(x, y) : |(x, y)− (x1, y1)| ≤ cd(s− t1)}.
Observe that A(x1, y1, t1) is the region inside Va(t0) ∪ Vb(t0) that is affected by a
mutation at (x1, y1, t1), so A(x1, y1, t1) = U1 ∩ (Va(t0) ∪ Vb(t0)). This of course
implies that
|(Va(t0) ∪ Vb(t0)) \A(x1, y1, t1)| = |Va(t0) ∪ Vb(t0)| − |A(x1, y1, t1)|,
It thus remains to find |A(x1, y1, t1)|. This will be accomplished by looking at
the cross-sections of this set for each fixed time s. Define va(s) and vb(s) as the
cross section of Va and Vb, respectively, at time s, i.e.,
va(s) = {(x, y) : |(x, y)− a| ≤ cd(t0 − s)}
vb(s) = {(x, y) : |(x, y)− b| ≤ cd(t0 − s)}.
If (x1, y1, t1) ∈ Va(t0) \ Vb(t0), then U1 will not intersect Vb(t0), so in this case
A(x1, y1, t1) = U1∩Va(t0). In order to compute the volume of this set we look at the
area of the cross section for each fixed time point. There are three distinct regions
for the behavior of the area of this cross section. In the first section of time the
cross section of U1 is contained in the cross section of Va:
u1(s) ∩ va(s) = u1(s)
⇐⇒ u1(s) ⊂ va(s)
⇐⇒ ra + cd(s− t1) < cd(t0 − s)
⇐⇒ s < t1 + t0
2
− ra
2cd
.
In the final section of time the cross section of Va is contained in the cross section
of U1:
u1(s) ∩ va(s) = va(s)
⇐⇒ va(s) ⊂ u1(s)
⇐⇒ ra + cd(t0 − s) < cd(s− t1)
⇐⇒ s > t1 + t0
2
+
ra
2cd
.
When
t1 + t0
2
− ra
2cd
< s <
t1 + t0
2
+
ra
2cd
:
|u1(s) ∩ va(s)| = Ru2(s) cos−1
(
du(s)
Ru(s)
)
− du(s)
√
R2u(s)− d2u(s) + Rˆ2a(s) cos−1
(
dˆa(s)
Rˆa(s)
)
− dˆa(s)
√
Rˆ2a(s)− dˆ2a(s),
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where Ru(s) = cd(s − t1), Rˆa(s) = cd(t0 − s), du(s) = r
2
a − Rˆ2a(s) +R2u(s)
2ra
, and
dˆa(s) =
r2a + Rˆ
2
a(s)−R2u(s)
2ra
.
Thus for (x1, y1, t1) ∈ Va(t0) \ Vb(t0):
|A(x1, y1, t1)| (30)
=
∫ t1+t0
2
− ra
2cd
t1
|u1(s)|ds+
∫ t1+t0
2
+ ra
2cd
t1+t0
2
− ra
2cd
|u1(s) ∩ va(s)|ds+
∫ t0
t1+t0
2
+ ra
2cd
|va(s)|ds
|A(x1, y1, t1)| is computed analogously when (x1, y1, t1) ∈ Vb(t0) \ Va(t0).
It remains to compute |A(x1, y1, t1)| when (x1, y1, t1) ∈ Vb(t0) ∩ Va(t0). First
note that if (x1, y1, t1) ∈ Vb(t0) ∩ Va(t0):
u1(s) ∩ (va(s) ∪ vb(s)) = u1(s)
⇐⇒ u1(s) ⊂ (va(s) ∪ vb(s))
⇐⇒ s < t1 + t0
2
− min{ra, rb}
2cd
.
= s1.
Once the cross-sections va(s) and vb(s) are no longer intersecting i.e., when
s > t0 − r2cd , then
|u1(s) ∩ (va(s) ∪ vb(s))| = |u1(s) ∩ va(s)|+ |u1(s) ∩ vb(s)|.
The two quantities |u1(s) ∩ va(s)| and |u1(s) ∩ vb(s)| can be calculated as shown
above.
Then for
t1 + t0
2
− min{ra, rb}
2cd
< s < t0 − r
2cd
:
|u1(s) ∩ (va(s) ∪ vb(s))| = |u1(s) ∩ va(s)|+ |u1(s) ∩ vb(s)| − |u1(s) ∩ va(s) ∩ vb(s)|.
|u1(s) ∩ va(s)| and |u1(s) ∩ vb(s)| can be calculated as shown above, and the
quantity |u1(s) ∩ va(s) ∩ vb(s)| can be calculated as shown in [27].
Thus if (x1, y1, t1) ∈ Va(t0) ∩ Vb(t0), then
|A(x1, y1, t1)| (31)
=
∫ s1
t1
|u1(s)|ds+
∫ t0−r/(2cd)
s1
|u1(s) ∩ (va(s) ∪ vb(s))|ds.
With (30) and (31) we can compute |A(x1, y1, t1)| for arbitrary (x1, y1, t1). We can
then use |A(x1, y1, t1)| with (29) and (28) to compute (26) and (27). Finally we use
(26) and (27) compute P (Dab|E2) based on (25).
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C I2 Calculations
In this section we describe how to compute I2(r, t) and I2(r, τ). First recall from
Section 4.2 that R is the radius of the clone, Y , chosen according to a size-biased
pick, and X is the distance of p (a point selected at random from Y ) from the center
of Y .
We first describe how to estimate I2(r, t) based on (11). In particular, we can
generate K i.i.d copies of the vector (X,R), denoted by {(Xi, Ri)}Ki=1. Our method
for generating (X1, R1) based on the time interval [0, t] is as follows. First generate
the arrival times of mutations based on a Poisson process with rate Nu1s, denote
this set of times by t1, . . . , tn.. Then for each mutation calculate the size of its
family at time t using the formula (7), this gives us the collection of family sizes
Y1,1, . . . , Y1,n of clones C1,1, . . . , C1,n . Choose a clone C = C[1] via a size biased
pick from the collection C1,1, . . . , C1,n, and set R to be the radius of C. Let U be a
uniform random variable on [0, 1] independent of R and set X = R
√
U . With these
samples form the estimator
Iˆ2(r, t) =
1
K
K∑
i=1
P (p2 ∈ C|Ri, Xi).
We can also derive an alternative representation for P (p2 ∈ C) that is more
suitable for mathematical analysis. Denote the conditional density of X given R = y
by fX(x|R = y) and the density of R by fR. It’s easy to see that fX(x|R = y) = 2xy2
for x ∈ (0, y) and 0 otherwise, and therefore
P (p2 ∈ C) =
∫ ∞
r
∫ y−r
0
2x
y2
fR(y)dxdy +
∫ r
r/2
∫ y
r−y
φ(x, y)
2x
y2
fR(y)dxdy
+
∫ ∞
r
∫ y
y−r
φ(x, y)
2x
y2
fR(y)dxdy
=
∫ ∞
r
(y − r)2
y2
fR(y)dy +
∫ r
r/2
∫ y
r−y
φ(x, y)
2x
y2
fR(y)dxdy
+
∫ ∞
r
∫ y
y−r
φ(x, y)
2x
y2
fR(y)dxdy. (32)
Define
ψr(R) =
2
R2
∫ R
|R−r|
xφ(x,R)dx
and
Φr(R) =

(R−r)2
R2
+ ψr(R), R ≥ r
ψr(R), R ∈ (r/2, r)
0, R ≤ r/2.
Therefore we see from (32) that we have P(p2 ∈ C) = E[Φr(R)].
The formula P(p2 ∈ C) = E[Φr(R)] is difficult to work with due to the complex
distribution of R. However, an interesting observation is that the distribution of
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R becomes much simpler if we assume that the sampling occurs at the random
detection time τ . In this case define R(τ) to be the radius of the clone that we
choose at time τ , then we can use equation (9) in [9] to see that conditional on
τ = t, R(τ) has density
f(x|t) = µγdx
d
cd(1− e−θtd+1)
exp
[
− µγdr
d+1
cd(d+ 1)
]
for x ≤ cdt and zero otherwise. In the conditional density above θ = µγcdd/(d+ 1).
In order to describe the distribution of R(τ) we then need the distribution of τ ,
which we can get from (4) of [9]. In particular define
φ(t) =
1
t
∫ t
0
exp
(
−θrd+1
)
dr,
and λ = Nu1s then τ has density
fτ (t) = λe
tλ(φ(t)−1)
(
1− e−θtd+1
)
.
Therefore we can calculate that
P (R(τ) > z) =
µγdλ
cd
∫ ∞
z/cd
∫ cdt
z
rd exp
[
− µγdr
d+1
cd(d+ 1)
]
dretλ(φ(t)−1)dt
= λ
∫ ∞
z/cd
(
exp
(
−θ(z/cd)d+1
)
− exp
(
−θtd+1
))
etλ(φ(t)−1)dt
= exp [λ(z/cd)(φ(z/cd)− 1)]− λ
[
1− exp
(
−θ(z/cd)d+1
)] ∫ ∞
z/cd
eλt(φ(t)−1)dt.
Furthermore we can take derivatives to find that R(τ) has density given by
fˆR(z) =
λθ(d+ 1)
cd+1d
zd exp
[
−θ
(
z
cd
)d+1]∫ ∞
z/cd
etλ(φ(t)−1)dt.
Note that the density fˆ is very similar to the Weibull density, and thus we can
generate samples from fˆ by using the acceptance rejection algorithm with a proposal
distribution based on the Weibull distribution. With these samples from the density
fˆ then we can use the function Φr to estimate I2(r, τ).
Note that when approximating I2(r, τ) it is not necessary to simulate the meso-
scopic model. We simply generate random variables according to the density fˆR
and then evaluate the function Φr(R). However, when approximating I2(r, t) it
is necessary to simulate the mesoscopic model and thus a greater computational
burden.
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